Datavant to Acquire Aetion, Creating an End-to-End Real-World Evidence Platform
July 13, 2025
Datavant signed an agreement to acquire Aetion, a real-world evidence (RWE) platform used for healthcare and life sciences decision-making. The combined offering is intended to provide end-to-end RWE capabilities spanning data discovery, linkage, privacy, curation, and advanced analysis for regulators and industry stakeholders.
- Buyers
- Datavant
- Targets
- Aetion
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.